Pathophysiologic insights into motor axonal function in Kennedy disease

Neurology

Volumn 69, Issue 19, 2007, Pages 1828-1835

  Vucic, Steve ^a,b   Kiernan, Matthew C ^a,b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABDUCTOR POLLICIS BREVIS; ACTION POTENTIAL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; KENNEDY DISEASE; MALE; MOTOR PERFORMANCE; MUSCLE; NERVE EXCITABILITY; NERVE FIBER; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 35948960336     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000279521.81846.59     Document Type: Article

References (58)

1. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 1968;18:671-680.
2. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991;352:77-79.
3. Gallo JM. Spinobulbar muscular atrophy (Kennedy's disease). In: AE, ed. Clinical neurophysiology of motor neuron diseases. Handbook of clinical neurophysiology. Amsterdam: Elsevier BV, 2004;209-214.
4. Harding AE, Thomas PK, Baraitser M, Bradbury PG, Morgan-Hughes JA, Ponsford JR. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J Neurol Neurosurg Psychiatry 1982;45:1012-1019.
5. Olney RK, Aminoff MJ, So YT. Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy. Neurology 1991;41:823-828.
6. Hirota N, Eisen A, Weber M. Complex fasciculations and their origin in amyotrophic lateral sclerosis and Kennedy's disease. Muscle Nerve 2000;23:1872-1875.
7. Meriggioli MN, Rowin J, Sanders DB. Distinguishing clinical and electrodiagnostic features of X-linked bulbospinal neuronopathy. Muscle Nerve 1999;22:1693-1697.
8. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronopathy. A clinicopathological study. Brain 1989;112:209-232.
9. Trojaborg W, Wulff CH. X-linked recessive bulbospinal neuronopathy (Kennedy's syndrome): a neurophysiological study. Acta Neurol Scand 1994;89:214-219.
10. Ferrante MA, Wilbourn AJ. The characteristic electrodiagnostic features of Kennedy's disease. Muscle Nerve 1997;20:323-329.
11. Conradi S, Grimby L, Lundemo G. Pathophysiology of fasciculations in ALS as studied by electromyography of single motor units. Muscle Nerve 1982;5:202-208.
12. Miller TM, Layzer RB Muscle cramps. Muscle Nerve 2005;32:431-442.
13. Layzer RB. The origin of muscle fasciculations and cramps. Muscle Nerve 1994;17:1243-1249.
14. Roth G. The origin of fasciculations. Ann Neurol 1982;12:542-547.
15. Roth G. Fasciculations and their F-response. Localisation of their axonal origin. J Neurol Sci 1984;63:299-306.
16. Wettstein A. The origin of fasciculations in motoneuron disease. Ann Neurol 1979;5:295-300.
17. Kiernan MC, Burke D. Threshold electronus in the assessment of motor neuron disease. In: Mauguiere F, ed. Handbook of clinical neurophysiology. Amsterdam: Elsevier, 2004.
18. Mogyoros I, Kiernan MC, Burke D, Bostock H. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 1998;121:851-859.
19. Kanai K, Kuwabara S, Misawa S, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006;129:953-962.
20. Vucic S, Kiernan M. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006;117:1458-1466.
21. Maddison P, Newsom-Davis J, Mills KR. Strength-duration properties of peripheral nerve in acquired neuromyotonia. Muscle Nerve 1999;22:823-830.
22. Nagado T, Arimura K, Sonoda Y, et al. Potassium current suppression in patients with peripheral nerve hyperexcitability. Brain 1999;122:2057-2066.
23. Kiernan MC, Hart IK, Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 2001;70:56-64.
24. Andrew SE, Goldberg YP, Hayden MR. Rethinking genotype and phenotype correlations in polyglutamine expansion disorders. Hum Mol Genet 1997;6:2005-2010.
25. Medical Research Council. Aid to the examination of the peripheral nervous system. London: Her Majesty's Stationary Office, 1976.
26. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000;23:399-409.
27. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998;21:137-158.
28. Weiss G. Sur la possibilité de rendre comparables entre eux les appareils servant l'excitation électrique. Arch Ital Biol 1901;35:413-446.
29. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996;119:439-447.
30. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol 2001;112:1575-1585.
31. Kiernan MC, Cikurel K, Bostock H. Effects of temperature on the excitability properties of human motor axons. Brain 2001;124:816-825.
32. Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol (Lond) 1997;498 (Pt 1):277-294.
33. Bostock H. The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J Physiol (Lond) 1983;341:59-74.
34. Baker M, Bostock H, Grafe P, Martius P. Function and distribution of three types of rectifying channel in rat spinal root myelinated axons. J Physiol (Lond) 1987;383:45-67.
35. Pape HC. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu Rev Physiol 1996;58:299-327.
36. Bostock H, Baker M. Evidence for two types of potassium channel in human motor axons in vivo. Brain Res 1988;462:354-358.
37. Kiernan MC, Mogyoros I, Burke D. Differences in the recovery of excitability in sensory and motor axons of human median nerve. Brain 1996;119:1099-1105.
38. Barrett EF, Barrett JN. Intracellular recording from vertebrate myelinated axons: mechanism of the depolarizing afterpotential. J Physiol (Lond) 1982;323:117-144.
39. Waxman SG, Ritchie JM. Molecular dissection of the myelinated axon. Ann Neurol 1993;33:121-136.
40. Doyu M, Sobue G, Mukai E, et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 1992;32:707-710.
41. La Spada AR, Roling DB, Harding AE, et al. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat Genet 1992;2:301-304.
42. Zoghbi HY, Orr HT. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000;23:217-247.
43. Kiernan M, Burke D. Threshold electrotonus in the assessment of motor neuron disease. In: Daube J, Mauguiere F, eds. Handbook of clinical neurophysiology. Amsterdam: Elsevier, 2004:359-366.
44. Bromberg MB, Larson WL. Relationships between motor-unit number estimates and isometric strength in distal muscles in ALS/MND. J Neurol Sci 1996;139 suppl:38-42.
45. Kanai K, Kuwabara S, Arai K, Sung JY, Ogawara K, Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 2003;126 (Pt 4):965-973.
46. Sobue G. X-linked recessive bulbospinal neuronopathy (SBMA). Nagoya J Med Sci 1995;58:95-106.
47. Mogyoros I, Kiernan MC, Gracies JM, Burke D. The effect of stimulus duration on the latency of submaximal nerve volleys. Muscle Nerve 1996;19:1354-1356.
48. Brismar T. Electrical properties of isolated demyelinated rat nerve fibres. Acta Physiol Scand 1981;113:161-166.
49. Sar M, Stumpf WE. Androgen concentration in motor neurons of cranial nerves and spinal cord. Science 1977;197:77-79.
50. Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 1990;294:76-95.
51. Yu WH, McGinnis MY. Androgen receptor levels in cranial nerve nuclei and tongue muscles in rats. J Neurosci 1986;6:1302-1307.
52. Menard CS, Harlan RE. Up-regulation of androgen receptor immunoreactivity in the rat brain by androgenicanabolic steroids. Brain Res 1993;622:226-236.
53. Kiernan MC, Mogyoros I, Burke D. Changes in excitability and impulse transmission following prolonged repetitive activity in normal subjects and patients with a focal nerve lesion. Brain 1996;119:2029-2037.
54. Kiernan MC, Mogyoros I, Hales JP, Gracies JM, Burke D. Excitability changes in human cutaneous afferents induced by prolonged repetitive axonal activity. J Physiol (Lond) 1997;500 (Pt 1):255-264.
55. Kiernan MC, Lin CS, Burke D. Differences in activity-dependent hyperpolarization in human sensory and motor axons. J Physiol (Lond) 2004;558:341-349.
56. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000;123:2542-2551.
57. Stys PK, Waxman SG, Ransom BR. Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter. Ann Neurol 1991;30:375-380.
58. Stys PK. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J Cereb Blood Flow Metab 1998;18:2-25.